GlaxoSmithKline PLC News Headlines

GSK 
$46.52
*  
0.24
0.52%
Get GSK Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
GlaxoSmithKline Positioning For Clinical Trial Data Advantage
11/26/2012 11:07:00 AM - Seeking Alpha


BASF's Deal For Pronova Shows The Importance Of Good Nutrition (DD, BASFY, AMRN, GSK)
11/23/2012 12:09:00 PM - Investopedia


Bristol-Myers Squibb Demonstrates Impressive Cash Flows
11/23/2012 2:34:00 AM - Seeking Alpha


Buy GlaxoSmithKline If It Rises Above $45
11/22/2012 4:34:00 AM - Seeking Alpha


Applying The Venture Capital Model To Public Companies: Hugh Cleland
11/21/2012 3:18:00 PM - Seeking Alpha


Waiting For Fiscal Cliff Fallout Isn't 'Market Timing'
11/20/2012 10:45:00 AM - Seeking Alpha


Bristol-Myers Squibb: Juicy Dividends Set To Continue
11/15/2012 6:48:00 PM - Seeking Alpha


Teva Is Still Healthier Than Its Big Pharma Peers
11/14/2012 2:00:00 PM - Seeking Alpha


'Super' Novavax: Company Outshines Stars Of Pandemic Influenza Vaccine Production
11/14/2012 10:24:00 AM - Seeking Alpha


Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth
11/13/2012 6:55:00 AM - Seeking Alpha


3 Biopharma Catalyst Trades To Consider
11/13/2012 4:55:00 AM - Seeking Alpha


Dynavax Upcoming Binary Event: HBV Vaccine Under Review By FDA Advisory Panel
11/12/2012 1:42:00 PM - Seeking Alpha


Analyst Scott Power Finds The Upside In Biotech Down Under
11/8/2012 2:33:00 PM - Seeking Alpha


Amicus Therapeutics Poised For Rebound Into December Phase III Results
11/8/2012 11:53:00 AM - Seeking Alpha


3 Addiction Fighting Pharmas To Consider Now
11/7/2012 11:15:00 AM - Seeking Alpha


Amarin Stagnates On Frustrating M&A Speculation And (More) Waiting
11/6/2012 9:15:00 PM - Seeking Alpha


New Reasons To Be Bullish On Sanofi
11/6/2012 4:45:00 PM - Seeking Alpha


Despite Safety Concerns, Dynavax's Heplisav Should Receive FDA Approval
11/6/2012 10:55:00 AM - Seeking Alpha


4 Reasons To Buy This Top Pharma Stock For A Near 5% Yield
11/5/2012 8:19:00 AM - Seeking Alpha


How Does The Patent Exclusivity Factor Affect The 3 Top Dividend-Paying Healthcare Companies?
11/2/2012 7:43:00 AM - Seeking Alpha


GlaxoSmithKline's Results Down - Dividends Up
11/1/2012 12:54:00 PM - Seeking Alpha


5 Strong Pharmaceuticals To Buy Now For Gains In 2013
11/1/2012 6:08:00 AM - Seeking Alpha


Abbott: Cash In On This Big Pharma's Recent Pullback Now
10/26/2012 6:37:00 PM - Seeking Alpha


With AstraZeneca's Results Down Is Its Dividend Safe?
10/25/2012 11:34:00 AM - Seeking Alpha


8 Sectors And Dow 'Septober' Dividend Dog Report
10/24/2012 11:24:00 AM - Seeking Alpha